Related by context. Frequent words. (Click for all words.) 60 antisense drug 60 orally bioavailable 58 injectable formulation 58 humanized monoclonal antibody 57 anticancer agent 57 investigational oral 56 OXi# 56 CYT# 56 investigational 56 MGCD# [001] 56 AP# [003] 56 investigational compounds 55 CA4P 55 Avastin bevacizumab 55 immunomodulator 55 HDAC inhibitor 55 intravenously administered 54 DB# [003] 54 Everolimus 54 Nimotuzumab 53 Perifosine 53 orally administered 53 BiTE antibody 53 Molecular Cancer 52 BAY #-# 52 diabetic neuropathic pain 52 Phase IIa trial 52 immunotherapeutic 52 cancer immunotherapy 52 Orphan Drug 52 Phenoptin 52 investigational compound 52 MOZOBIL 52 pralatrexate 52 TREANDA 51 investigational drug 51 methylnaltrexone 51 preclinical studies 51 Orphan Drug designation 51 tezampanel 50 prodrug 50 ADVEXIN 50 oral formulation 50 Phase III clinical trials 50 PS# [001] 50 Picoplatin 50 NexACT 50 TELCYTA 50 Homspera 50 INDs 49 angiogenesis inhibitors 49 Apoptosis 49 Pharmacological 49 Rifaximin 49 clinical trials 49 teduglutide 49 relapsed multiple myeloma 49 temsirolimus 49 eltrombopag 49 Investigational 49 Biologics License Application BLA 49 Ceftobiprole 48 DR Cysteamine 48 ZYBRESTAT 48 Ampligen R 48 NKTR 48 Biologics License Application 48 Phase 2a trial 48 NGX# 48 Marketing Authorization Application 48 Phase Ib 48 CRx 48 Orphan Drug Designation 48 Serdaxin 48 biologic therapy 48 preclinical 48 Investigational Device Exemption IDE 47 Satraplatin 47 Phase 2a clinical 47 recombinant human 47 Marqibo 47 RDEA# 47 PEG Interferon lambda 47 Phase 2b trial 47 clinical trial 47 angiogenic 47 Ipilimumab 47 diabetic macular edema DME 47 RG# [001] 47 VEGF Trap 47 T DM1 46 Phase 2b clinical 46 perifosine 46 Rivaroxaban 46 MD Ph.D 46 opioid analgesic 46 phase IIb 46 intravenous formulation 46 alogliptin 46 IND enabling 46 phase IIa